NEWS
Drug Discovery News I Goodbye biopsies, non-invasive diagnostics for fatty liver disease are here

From last night’s happy hour drinks to this morning’s greasy breakfast burrito and ibuprofen, the liver has seen it all. As both factory and filter, the liver is a jack of all trades. It removes harmful toxins from the blood, creates bile to carry away waste, metabolizes drugs, stores iron and other vitamins, and even […]

Drug Discovery & Development I Axogen announces positive topline data from Phase 3 nerve graft study

Focused on developing peripheral nerve regeneration and repair products, Axogen (Nasdaq:AXGN) announced that the Phase 3 RECON study met its primary endpoint in comparing its Avance nerve graft to conduits in digital nerve injuries. The primary endpoint was the return of sensory function based on static two-point discrimination. This test measures the ability to detect that two […]

BioSpace I How to Navigate a Career Change From Biotech To Pharma

Last week, we looked at how to make a career change from biotech to pharma. Specifically, we discussed how the line between biotech and pharma companies is getting more blurred, year by year. The two have more in common than many might think. That’s good news if you’re looking to make the move from biotech to […]